BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31314706)

  • 21. Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China.
    Liu X; Yu Y; Li M; Liang G; Wang H; Jia L; Dong G
    Vaccine; 2011 Mar; 29(11):2127-30. PubMed ID: 21237278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced neutralizing antibody titer against genotype I virus in swine immunized with a live-attenuated genotype III Japanese encephalitis virus vaccine.
    Fan YC; Chen JM; Chen YY; Lin JW; Chiou SS
    Vet Microbiol; 2013 May; 163(3-4):248-56. PubMed ID: 23415032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection of swine by potent neutralizing anti-Japanese encephalitis virus monoclonal antibodies derived from vaccination.
    Young CL; Lyons AC; Hsu WW; Vanlandingham DL; Park SL; Bilyeu AN; Ayers VB; Hettenbach SM; Zelenka AM; Cool KR; Peterson GJ; Higgs S; Huang YS
    Antiviral Res; 2020 Feb; 174():104675. PubMed ID: 31825852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
    Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
    Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poly-γ-glutamic acid nanoparticles and aluminum adjuvant used as an adjuvant with a single dose of Japanese encephalitis virus-like particles provide effective protection from Japanese encephalitis virus.
    Okamoto S; Yoshii H; Matsuura M; Kojima A; Ishikawa T; Akagi T; Akashi M; Takahashi M; Yamanishi K; Mori Y
    Clin Vaccine Immunol; 2012 Jan; 19(1):17-22. PubMed ID: 22089248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction and Immunogenicity of Recombinant Vaccinia Virus Vaccine Against Japanese Encephalitis and Chikungunya Viruses Infection in Mice.
    Zhang Y; Han JC; Jing J; Liu H; Zhang H; Li ZH; Jin NY; Lu HJ
    Vector Borne Zoonotic Dis; 2020 Oct; 20(10):788-796. PubMed ID: 32584657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization with recombinant adenovirus synthesizing the secretory form of Japanese encephalitis virus envelope protein protects adenovirus-exposed mice against lethal encephalitis.
    Appaiahgari MB; Saini M; Rauthan M; Jyoti ; Vrati S
    Microbes Infect; 2006 Jan; 8(1):92-104. PubMed ID: 16126425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Envelope protein gene based molecular characterization of Japanese encephalitis virus clinical isolates from West Bengal, India: a comparative approach with respect to SA14-14-2 live attenuated vaccine strain.
    Sarkar A; Banik A; Pathak BK; Mukhopadhyay SK; Chatterjee S
    BMC Infect Dis; 2013 Aug; 13():368. PubMed ID: 23927571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice.
    Gromowski GD; Firestone CY; Whitehead SS
    J Virol; 2015 Jun; 89(12):6328-37. PubMed ID: 25855730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological and genetic properties of SA₁₄-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans.
    Song BH; Yun GN; Kim JK; Yun SI; Lee YM
    J Microbiol; 2012 Aug; 50(4):698-706. PubMed ID: 22923123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of cross-protection against two wild-type Taiwanese isolates of Japanese encephalitis virus using Beijing-1 strain DNA vaccine.
    Wu CJ; Huang HW; Tao MH
    Vaccine; 2003 Sep; 21(25-26):3938-45. PubMed ID: 12922129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A plasmid encoding Japanese encephalitis virus PrM and E proteins elicits protective immunity in suckling mice.
    Wu Y; Zhang F; Ma W; Song J; Huang Q; Zhang H
    Microbiol Immunol; 2004; 48(8):585-90. PubMed ID: 15322338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Partially neutralizing potency against emerging genotype I virus among children received formalin-inactivated Japanese encephalitis virus vaccine.
    Fan YC; Chen JM; Chiu HC; Chen YY; Lin JW; Shih CC; Chen CM; Chang CC; Chang GJ; Chiou SS
    PLoS Negl Trop Dis; 2012; 6(9):e1834. PubMed ID: 23029592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction and immune efficacy of recombinant pseudorabies virus expressing PrM-E proteins of Japanese encephalitis virus genotype І.
    Qian P; Zhi X; Wang B; Zhang H; Chen H; Li X
    Virol J; 2015 Dec; 12():214. PubMed ID: 26651827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant chimeric Japanese encephalitis virus/tick-borne encephalitis virus is attenuated and protective in mice.
    Wang HJ; Li XF; Ye Q; Li SH; Deng YQ; Zhao H; Xu YP; Ma J; Qin ED; Qin CF
    Vaccine; 2014 Feb; 32(8):949-56. PubMed ID: 24394443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacterially expressed recombinant envelope protein domain III of Japanese encephalitis virus (rJEV-DIII) elicits Th1 type of immune response in BALB/c mice.
    Verma SK; Kumar S; Gupta N; Vedi S; Bhattacharya SM; Lakshmana Rao PV
    Vaccine; 2009 Nov; 27(49):6905-9. PubMed ID: 19761840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell immunity rather than antibody mediates cross-protection against Zika virus infection conferred by a live attenuated Japanese encephalitis SA14-14-2 vaccine.
    Wang R; Zhen Z; Turtle L; Hou B; Li Y; Wu N; Gao N; Fan D; Chen H; An J
    Appl Microbiol Biotechnol; 2020 Aug; 104(15):6779-6789. PubMed ID: 32556415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.
    Hegde NR; Gore MM
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-18. PubMed ID: 28301270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers.
    Van Gessel Y; Klade CS; Putnak R; Formica A; Krasaesub S; Spruth M; Cena B; Tungtaeng A; Gettayacamin M; Dewasthaly S
    Vaccine; 2011 Aug; 29(35):5925-31. PubMed ID: 21723353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Japanese encephalitis virus structural and nonstructural proteins expressed in Escherichia coli induce protective immunity in mice.
    Tafuku S; Miyata T; Tadano M; Mitsumata R; Kawakami H; Harakuni T; Sewaki T; Arakawa T
    Microbes Infect; 2012 Feb; 14(2):169-76. PubMed ID: 22001496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.